Prudential > Prudential Sector Funds, Inc.
PGIM Jennison Health Sciences Fund
$1.61B
Avg Monthly Net Assets
$1.79B
Total Assets
$33.06M
Total Liabilities
$1.75B
Net Assets
PGIM Jennison Health Sciences Fund is a Mutual Fund in Prudential Sector Funds, Inc.
from Prudential,
based in New Jersey,
United States of America.
The fund has five share classes
and monthly net assets of $1.61B.
On July 29th, 2024 it reported 55 holdings, the largest
being Eli Lilly & Co (12.9%), Merck & Co Inc (8.3%) and Vertex Pharmaceuticals Inc (4.8%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class A | C000012121 | PHLAX | |
| Class C | C000012123 | PHLCX | |
| Class R | C000110073 | PJHRX | |
| Class R6 | C000165347 | PHLQX | |
| Class Z | C000012124 | PHSZX |
Holdings
From latest NPORT-P, filed July 29th, 2024 for period ending May 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| (PIPA070) PGIM Core Government Money Market Fund | Long | Short-term investment vehicle | US | $48M | 48M | 2.72 |
| Agilent Technologies Inc | Long | Equity-common | US | $19M | 143K | 1.06 |
| Alto Neuroscience Inc | Long | Equity-common | US | $3M | 242K | 0.17 |
| Amgen Inc | Long | Equity-common | US | $78M | 254K | 4.43 |
| Apellis Pharmaceuticals Inc | Long | Equity-common | US | $45M | 1M | 2.58 |
| Apogee Therapeutics Inc | Long | Equity-common | US | $5M | 112K | 0.29 |
| Arcutis Biotherapeutics Inc | Long | Equity-common | US | $23M | 3M | 1.30 |
| Argenx SE | Long | Equity-common | NL | $48M | 128K | 2.72 |
| AstraZeneca PLC | Long | Equity-common | GB | $58M | 745K | 3.31 |
| Avantor Inc | Long | Equity-common | US | $13M | 537K | 0.74 |
| Becton Dickinson & Co | Long | Equity-common | US | $55M | 235K | 3.11 |
| Boston Scientific Corp | Long | Equity-common | US | $61M | 813K | 3.50 |
| Cabaletta Bio Inc | Long | Equity-common | US | $14M | 1M | 0.80 |
| Celldex Therapeutics Inc | Long | Equity-common | US | $12M | 363K | 0.69 |
| Cigna Group/The | Long | Equity-common | US | $37M | 107K | 2.10 |
| Cooper Cos Inc/The | Long | Equity-common | US | $25M | 265K | 1.42 |
| Crinetics Pharmaceuticals Inc | Long | Equity-common | US | $37M | 828K | 2.10 |
| Dyne Therapeutics Inc | Long | Equity-common | US | $21M | 662K | 1.20 |
| Eli Lilly & Co | Long | Equity-common | US | $226M | 276K | 12.90 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $17M | 224K | 1.00 |
| Hologic Inc | Long | Equity-common | US | $17M | 227K | 0.95 |
| Humana Inc | Long | Equity-common | US | $69M | 192K | 3.91 |
| Ideaya Biosciences Inc | Long | Equity-common | US | $7M | 204K | 0.42 |
| Inari Medical Inc | Long | Equity-common | US | $24M | 472K | 1.35 |
| Insmed Inc | Long | Equity-common | US | $13M | 241K | 0.76 |
| Intuitive Surgical Inc | Long | Equity-common | US | $53M | 131K | 3.01 |
| Krystal Biotech Inc | Long | Equity-common | US | $16M | 101K | 0.92 |
| Kymera Therapeutics Inc | Long | Equity-common | US | $7M | 225K | 0.41 |
| Kyverna Therapeutics Inc | Long | Equity-common | US | $3M | 234K | 0.17 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $6M | 338K | 0.36 |
| Lonza Group AG | Long | Equity-common | CH | $8M | 15K | 0.46 |
| Maravai LifeSciences Holdings Inc | Long | Equity-common | US | $21M | 2M | 1.20 |
| Marinus Pharmaceuticals Inc | Long | Equity-common | US | $1M | 844K | 0.07 |
| Merck & Co Inc | Long | Equity-common | US | $146M | 1M | 8.31 |
| Mineralys Therapeutics Inc | Long | Equity-common | US | $5M | 361K | 0.26 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $40M | 297K | 2.30 |
| Newamsterdam Pharma Co NV | Long | Equity-common | NL | $9M | 489K | 0.52 |
| Novo Nordisk A/S | Long | Equity-common | DK | $74M | 545K | 4.20 |
| PGIM Institutional Money Market Fund - D | Long | Short-term investment vehicle | US | $19M | 19M | 1.06 |
| Phathom Pharmaceuticals Inc | Long | Equity-common | US | $14M | 1M | 0.80 |
| QIAGEN NV | Long | Equity-common | NL | $30M | 691K | 1.71 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $56M | 58K | 3.21 |
| Savara Inc | Long | Equity-common | US | $14M | 3M | 0.77 |
| Solventum Corp | Long | Equity-common | US | $8M | 132K | 0.45 |
| Structure Therapeutics Inc | Long | Equity-common | US | $3M | 84K | 0.16 |
| Tandem Diabetes Care Inc | Long | Equity-common | US | $9M | 185K | 0.54 |
| Tarsus Pharmaceuticals Inc | Long | Equity-common | US | $8M | 249K | 0.47 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $34M | 60K | 1.95 |
| Tourmaline Bio Inc | Long | Equity-common | US | $5M | 347K | 0.27 |
| UnitedHealth Group Inc | Long | Equity-common | US | $80M | 162K | 4.59 |
| Vaxcyte Inc | Long | Equity-common | US | $25M | 355K | 1.42 |
| Vera Therapeutics Inc | Long | Equity-common | US | $9M | 231K | 0.50 |
| Verona Pharma PLC | Long | Equity-common | GB | $8M | 699K | 0.48 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $85M | 186K | 4.83 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $12M | 327K | 0.71 |
Address
Prudential Sector Funds, Inc.
655 Broad Street
Newark
New Jersey
07102-4077
United States of America
Websites
Directors
Keith F. Hartstein
Ellen S. Alberding
Laurie Simon Hodrick
Linda W. Bynoe
Kevin J. Bannon
Grace C. Torres
Brian K. Reid
Scott E. Benjamin
Stuart S. Parker
Barry H. Evans
Transfer Agents
BNY Mellon Investment Servicing (US) Inc.
Prudential Mutual Fund Services LLC
Pricing Services
Refinitiv US Holdings Inc.
Intercontinental Exchange, Inc.
S&P Global Market Intelligence
Bloomberg Finance L.P.
Custodians
UniCredit Bank Austria AG
Skandinaviska Enskilda Banken AB, Copenhagen Branch
The Bank of New York Mellon SA/NV, Asset Servicing, Niederlassung Frankfurt am Main
The Bank of New York Mellon (United Kingdom)
Citibanamex
MUFG Bank, Ltd.
Skandinaviska Enskilda Banken AB, Helsinki Branch
HSBC NOMINEES (NEW ZEALAND) LIMITED
Skandinaviska Enskilda Banken AB, Oslo Branch
CIBC Mellon Trust Company (Canada)
The Bank of New York Mellon, SA/NV (Netherlands)
Skandinaviska Enskilda Banken AB, Stockholm
TMX GROUP LIMITED
Bank Hapoalim B.M.
Credit Suisse (Switzerland) Ltd.
Citibank N.A., Brazilian Branch
HongKong and Shanghai Banking Corporation Limited
HSBC Bank Australia Limited
Banco Santander - Chile
STANDARD CHARTERED BANK (SINGAPORE) LIMITED
Euroclear France
The Bank of New York Mellon SA/NV (Belgium)
The Bank of New York Mellon
THE STANDARD BANK OF SOUTH AFRICA
HSBC Bank (China) Company Limited
The Bank of New York Mellon, SA/NV (Italy)
Banco Bilbao Vizcaya Argentaria SA
Euroclear Bank SA/NV (Belgium)
Citibank Europe plc. Hungarian Branch Office
Shareholder Servicing Agents
Prudential Mutual Fund Services LLC
Admins
PGIM INVESTMENTS LLC
Brokers
SVB Leerink LLC
RBC CAPITAL MARKETS, LLC
EVERCORE GROUP L.L.C.
KEYBANC CAPITAL MARKETS, INC.
TD SECURITIES (USA) LLC
BARCLAYS CAPITAL, INC.
SANFORD C. BERNSTEIN & CO., LLC
PIPER SANDLER & CO.
JEFFERIES LLC
ROBERT W. BAIRD & CO. INC.